ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,976, issued on Sept. 22, was assigned to Black Diamond Therapeutics Inc. (Cambridge, Mass.).
"Quinoxaline derivatives and uses thereof" was invented by Matthew C. Lucas (Lexington, Mass.) and Fernando Padilla (Arlington, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates compounds of Formula (I'):and pharmaceutically acceptable salts and stereoisomers thereof. The present disclosure also relates to methods of preparing the compounds, compositions comprising the compounds, and methods of using the compounds, e.g., in the treatment of cancer."
The patent was filed on Feb. 4, 2022, under Application No. 18/275,232.
*...